au.\*:("LEUCUTA S")
Results 1 to 15 of 15
Selection :
ETUDE PHYSICO-CHIMIQUE DE L'INTERACTION DU DIAZEPAM AVEC DES EXCIPIENTS HYDROPHILESNEAMTU M; LEUCUTA S.1980; ANN. PHARM. ER.; ISSN 0003-4509; FRA; DA. 1980 PUBL. 1981; VOL. 38; NO 6; PP. 507-511; ABS. ENG; BIBL. 7 REF.Article
ETUDE PHYSICO-CHIMIQUE DES DISPERSIONS SOLIDES HYDROPHILES DU PHENOBARBITALLEUCUTA S; NEAMTU M.1980; ANN. PHARM. FR.; ISSN 0003-4509; FRA; DA. 1980 PUBL. 1981; VOL. 38; NO 5; PP. 411-420; ABS. ENG; BIBL. 14 REF.Article
The kinetics of in vitro release and the pharmacokinetics of miotic response in rabbits of gelatin and albumin microspheres with pilocarpineLEUCUTA, S. E.International journal of pharmaceutics. 1989, Vol 54, Num 1, pp 71-78, issn 0378-5173Article
The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in manLEUCUTA, S. E.Pharmazie. 1988, Vol 43, Num 12, pp 845-848, issn 0031-7144Article
ETUDE PHYSICOCHIMIQUE DE L'INTERACTION ENTRE LE LAURYL SULFATE DE SODIUM ET QUELQUES ANTIBIOTIQUESLEUCUTA S; SCHWARTZ I; POPOVICI A et al.1976; FARMACIA; ROMAN.; DA. 1976; VOL. 24; NO 1; PP. 47-54; ABS. ANGL. RUSSE; BIBL. 21 REF.Article
Use of experimental design for identifying the most important formulation and technological variables in pelletization by powder layeringTOMUTA, I; LEUCUTA, S. E.STP pharma sciences. 2004, Vol 14, Num 3, pp 215-221, issn 1157-1489, 7 p.Article
Optimization of hydrophilic matrix tablets using a D-optimal designBODEA, A; LEUCUTA, S. E.International journal of pharmaceutics. 1997, Vol 153, Num 2, pp 247-255, issn 0378-5173Article
ESTIMATION OF DIAZEPAM BIOAVAILABILITY FROM TABLETS BY THE MEASUREMENT OF ITS CLINICAL EFFECTPOP R; MOLDOVAN O; FODOREANU L et al.1980; DRUGS EXPER. CLIN. RES.; CHE; DA. 1980; VOL. 6; NO 1; PP. 45-52; BIBL. 4 REF.Article
Preparation, in vitro release and skin absorption of hydrocortisone acetate from a liposome gelMOLDOVAN, M; LEUCUTA, S. E; BAKRI, A et al.Journal of drug delivery science and technology. 2006, Vol 16, Num 2, pp 127-132, 6 p.Article
Preparation and pharmaceutical/pharmacokinetic characterization of liposomes and nanoparticles loaded with epirubicinLEUCUTA, S. E; ACHIM, M; RISCA, R et al.STP pharma sciences. 2003, Vol 13, Num 5, pp 291-297, issn 1157-1489, 7 p.Article
Optimization of fluid bed formulations of metoprolol granules and tablets using an experimental designTOMUTA, I; ALECU, C; RUS, L. L et al.Drug development and industrial pharmacy. 2009, Vol 35, Num 9, pp 1072-1081, issn 0363-9045, 10 p.Article
Gelatin microspheres containing epirubicin: pharmaceutical, pharmacokinetic and antitumour effect characterizationACHIM, M; RISCA, R; DAICOVICIU, D et al.STP pharma sciences. 2002, Vol 12, Num 5, pp 275-282, issn 1157-1489, 8 p.Article
Relative bioavailability of different oral sustained release oxprenolol tabletsLEUCUTA, S. E; FOLLIDIS, M; CAPALNEANU, R et al.European journal of drug metabolism and pharmacokinetics. 1998, Vol 23, Num 2, pp 178-184, issn 0378-7966Conference Paper
Paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres : preparation and in vitro evaluationACHIM, M; TOMUTA, I; VLASE, L et al.Journal of drug delivery science and technology. 2008, Vol 18, Num 6, pp 410-416, issn 1773-2247, 7 p.Article
Bioavailability of nifedipine from different oral dosage forms in healthy volunteersLEUCUTA, S. E; VIDA-SIMITI, L; CAPRIOARA, M. G et al.Pharmazie. 1989, Vol 44, Num 5, pp 336-338, issn 0031-7144Article